AIMS: In heart failure (HF) iron deficiency (ID) is frequently observed and represents a major mortality risk factor. Purpose of this study was to evaluate the correlation between mortality and ID in a cohort of 661 consecutive patients hospitalized for HF worsening.METHODS AND RESULTS: Patients were grouped: (i)according to presence(+)/absence(-) of anaemia (A) and ID defined following World Health Organization (WHO) and European Society of Cardiology (ESC)-American College of Cardiology/American Heart Association/HF society of America (ACC/AHA/HFSA) definitions, respectively: Group A-ID- (n=123), Group A+ID- (n=80), Group A+ID+ (n=247), and Group A-ID+ (n=211); (ii) according to presence of absolute (serum ferritin < 100mug/L) and functional ID [ferritin between 100 and 300mug/L and transferrin saturation (TSAT) < 20%]; and (iii) according to TSAT <20% and ≥20%. Groups were not different for several clinical features but age, gender, kidney function, and chronic obstructive pulmonary disease. Average follow-up was 1.94year (±420days). Overall 5years mortality rate was 29.5%. Only anaemia and functional ID but not ID as defined by guidelines showed an impact on prognosis. Transferrin saturation <20% (n=360) patients showed worst prognosis compared to TSAT ≥20% (n=301) patients. In addition, functional ID patients showed worse prognosis compared patients with ferritin <100mug/L and TSAT <20% or ≥20% likely due to more severe chronic inflammatory status [C-reactive protein, 7.4 (interquartile range 2.7-22.6) and 3.2 (1.4-8.7) mg/L, P<0.0001 respectively].CONCLUSION: We confirmed that in HF anaemia is associated to a poor prognosis. Moreover, we showed that patients with TSAT <20% had worse prognosis compared to those with TSAT ≥20% but the composite of ferritin between 100 and 300mug/L and TSAT <20% identifies HF patients with the poorest survival rate.

Prognostic role of transferrin saturation in heart failure patients / J. Campodonico, F. Nicoli, I. Motta, M. Migone De Amicis, A. Bonomi, M. Cappellini, P. Agostoni. - In: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. - ISSN 2047-4873. - (2021). [Epub ahead of print] [10.1093/eurjpc/zwaa112]

Prognostic role of transferrin saturation in heart failure patients

Nicoli, Flavia;Motta, Irene;Migone De Amicis, Margherita;Cappellini, Maria;Agostoni, Piergiuseppe
2021

Abstract

AIMS: In heart failure (HF) iron deficiency (ID) is frequently observed and represents a major mortality risk factor. Purpose of this study was to evaluate the correlation between mortality and ID in a cohort of 661 consecutive patients hospitalized for HF worsening.METHODS AND RESULTS: Patients were grouped: (i)according to presence(+)/absence(-) of anaemia (A) and ID defined following World Health Organization (WHO) and European Society of Cardiology (ESC)-American College of Cardiology/American Heart Association/HF society of America (ACC/AHA/HFSA) definitions, respectively: Group A-ID- (n=123), Group A+ID- (n=80), Group A+ID+ (n=247), and Group A-ID+ (n=211); (ii) according to presence of absolute (serum ferritin < 100mug/L) and functional ID [ferritin between 100 and 300mug/L and transferrin saturation (TSAT) < 20%]; and (iii) according to TSAT <20% and ≥20%. Groups were not different for several clinical features but age, gender, kidney function, and chronic obstructive pulmonary disease. Average follow-up was 1.94year (±420days). Overall 5years mortality rate was 29.5%. Only anaemia and functional ID but not ID as defined by guidelines showed an impact on prognosis. Transferrin saturation <20% (n=360) patients showed worst prognosis compared to TSAT ≥20% (n=301) patients. In addition, functional ID patients showed worse prognosis compared patients with ferritin <100mug/L and TSAT <20% or ≥20% likely due to more severe chronic inflammatory status [C-reactive protein, 7.4 (interquartile range 2.7-22.6) and 3.2 (1.4-8.7) mg/L, P<0.0001 respectively].CONCLUSION: We confirmed that in HF anaemia is associated to a poor prognosis. Moreover, we showed that patients with TSAT <20% had worse prognosis compared to those with TSAT ≥20% but the composite of ferritin between 100 and 300mug/L and TSAT <20% identifies HF patients with the poorest survival rate.
Anaemia; Heart failure; Iron deficiency:
Settore MED/09 - Medicina Interna
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
23-feb-2021
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Article (author)
File in questo prodotto:
File Dimensione Formato  
2021_Campodonico.pdf

non disponibili

Tipologia: Publisher's version/PDF
Dimensione 338.49 kB
Formato Adobe PDF
338.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/828943
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 6
social impact